| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||||
Research and development | ||||||||||
96,649 | 135,001 | 148,238 | 146,868 | 133,220 | 86,597 | 0 | 0 | 0 | 0 | 0 |
General and administrative | ||||||||||
35,054 | 34,962 | 33,278 | 30,361 | 26,247 | 21,563 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | ||||||||||
131,703 | 169,963 | 181,516 | 177,229 | 159,467 | 108,160 | 0 | 0 | 0 | 0 | 0 |
Loss from operations | ||||||||||
-131,703 | -169,963 | -181,516 | -177,229 | -159,467 | -108,160 | 0 | 0 | 0 | 0 | 0 |
Interest income | ||||||||||
5,029 | 6,049 | 6,645 | 6,881 | 6,223 | 4,719 | 0 | 0 | 0 | 0 | 0 |
Loss before benefit for income taxes | ||||||||||
-126,674 | -163,914 | -174,871 | -170,348 | -153,244 | -103,441 | 0 | 0 | 0 | 0 | 0 |
Benefit for income taxes | ||||||||||
-4,209 | -2,047 | -2,221 | -350 | -178 | -214 | 0 | 0 | 0 | 0 | 0 |
Net loss | ||||||||||
-122,465 | -161,867 | -172,650 | -169,998 | -153,066 | -103,227 | 0 | 0 | 0 | 0 | 0 |
Net loss per share attributable to common shareholders—basic and diluted | ||||||||||
-0.48 | -0.55 | -0.49 | -0.68 | -1.27 | 4.58 | -0.51 | -1.11 | -6.45 | -8.25 | -6.69 |
Weighted average common shares outstanding—basic and diluted | ||||||||||
55,322 | 55,132 | 54,831 | 54,475 | 51,758 | 49,198 | 48,183 | 18,328 | 2,478 | 1,942 | 1,673 |
Comprehensive loss: | ||||||||||
Net loss | ||||||||||
-122,465 | -161,867 | -172,650 | -169,998 | -153,066 | -103,227 | 0 | 0 | 0 | - | - |
Other comprehensive income: | ||||||||||
Unrealized gain on short-term investments and currency translation adjustments, net of tax | ||||||||||
232 | 37 | 4 | 50 | 0 | - | 0 | 0 | - | - | - |
Total other comprehensive income | ||||||||||
232 | 37 | 0 | 0 | 0 | - | - | - | - | - | - |
Total comprehensive loss | ||||||||||
-122,233 | -161,830 | -172,588 | -169,897 | -153,058 | -103,231 | 0 | 0 | 0 | - | - |